Scientific Articles
Aug 03, 2021
Systemic immunoglobulin light chain (AL) amyloidosis is a rare but fatal disease. It results from clonal proliferation of plasma cells with excessive production of…
Aug 03, 2021
The recent decades have ushered in considerable advancements in the diagnosis and treatment of systemic light chain (AL) amyloidosis. As disease outcomes improve,…
Jun 30, 2021
Systemic immunoglobulin light-chain (AL) amyloidosis is characterized by deposition of amyloid fibrils of light chains produced by clonal CD38+ plasma cells.…
Jun 25, 2021
Background:
Transthyretin amyloidosis, also called ATTR amyloidosis, is a life-threatening disease characterized by progressive accumulation of misfolded…
Mar 10, 2021
A Rare Case of Cerebral Amyloidoma Mimicking a Hemorrhagic Malignant Central Nervous System Neoplasm
Cerebral amyloidoma is a rare form of amyloidosis with a localized tumor like an amyloid deposition in the brain composed of insoluble fibrillary protein with cross…
Jan 31, 2021
AA-amyloidosis is a systemic disease whose clinical course is characteristically dominated by the renal dysfunction. Patients typically present with nephrotic range…
Jan 10, 2021
Venetoclax is efficacious in relapsed/refractory t(11;14) multiple myeloma, thus warranting investigation in light-chain amyloidosis (AL). This retrospective cohort…
Jan 10, 2021
Background:
Despite emerging treatments for hereditary transthyretin (ATTRv) amyloidosis, the disease is often misdiagnosed, with reported diagnostic delays of up…
Jan 06, 2021
The International Society of Amyloidosis (ISA) developed criteria for assessing the haematologic response to treatment in light chain (AL) amyloidosis in 2012. The…
Jan 06, 2021
Hereditary transthyretin (hATTR) amyloidosis is a rare, systemic, progressive, and life-threatening disease in which transthyretin proteins misfold and aggregate as…